Given that the gene encoding S6K1, RPS6KB1, is amplified in about 8–10% of breast cancer patients (Bärlund et al., 2000), we decided to examine the sensitivity of breast cancer cell lines, with and without RPS6KB1 amplification, to chemotherapeutic agents. This evidence concerns the gene RPS6KB1 and breast carcinoma.